J Michael Lahey1, John J Kearney, Murat Tunc
1Permanente Medical Group, Hayward, California, Department of Ophthalmology, Retinal Division, Union City, CA 94587, USA. Mike.Lahey@kp.org
Central retinal vein occlusion (CRVO) evaluation should focus on common risk factors. Testing for antiphospholipid antibodies and elevated homocysteine is most useful, while extensive thrombophilia screening is rarely warranted for CRVO patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: